Dose-response in the treatment of breast cancer: a critical review.
about
Granulocyte-macrophage colony-stimulating factor (GM-CSF) allows acceleration and dose intensity increase of CEF chemotherapy: a randomised study in patients with advanced breast cancerGranulocyte-macrophage colony stimulating factor (GM-CSF) after high-dose melphalan in patients with advanced colon cancer.Phase I study of accelerated FEC with granulocyte colony-stimulating factor (Lenograstim) supportLaevofolinic acid, 5-fluorouracil, cyclophosphamide and escalating doses of epirubicin with granulocyte colony-stimulating factor support in locally advanced and/or metastatic breast carcinoma: a phase I-II study of the Southern Italy Oncology GroupPhase I oncology studies: evidence that in the era of targeted therapies patients on lower doses do not fare worseHigh-dose chemotherapy and autologous stem cell transplantation for breast cancer.High dose chemotherapy: rationale and results in breast carcinoma.High-dose chemotherapy for breast cancer?Dose intensity in cancer chemotherapyDose intensity analysis in advanced ovarian cancer patients.Haematological toxicity: a marker of adjuvant chemotherapy efficacy in stage II and III breast cancerChange in tumor size by RECIST correlates linearly with overall survival in phase I oncology studies.Cyclophosphamide, methotrexate and infusional 5-fluorouracil (infusional CMF) in metastatic breast cancerThe use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancerDose-dense epirubicin and paclitaxel with G-CSF: a study of decreasing intervals in metastatic breast cancer.Cancer therapy: reimbursement of new therapeutic technologiesDose-escalation of filgrastim does not improve efficacy: clinical tolerability and long-term follow-up on CALGB study 9141 adjuvant chemotherapy for node-positive breast cancer patients using dose-intensified doxorubicin plus cyclophosphamide followCurrent status of epirubicin (Farmorubicin) in the treatment of solid tumours.How to improve cytotoxic therapy in advanced breast cancer.Hemopoietic growth and inhibitory factors in treatment of malignancies. A review.A phase II trial of high dose epirubicin in patients with advanced breast carcinoma.High-dose therapy with peripheral blood stem cell (PBSC) support using an innovative mobilization regimen in patients with high-risk primary or chemoresponsive metastatic breast cancers
P2860
Q28378467-F11B7F25-F0CD-4F88-A46A-F74F7644528BQ33372338-1524FD62-5C6C-4389-AE96-0179331940E9Q33488249-64226752-0EEE-466D-8551-35103BE7E74AQ33488519-3DA17761-AE5B-4E74-A5D3-39AB34B24D06Q33658203-A5879942-771E-4792-9207-43B239DECC5FQ33931132-80295385-9816-4DC5-8DDB-725CC1C3BAB6Q33970577-1617CACC-1486-4895-BAA0-A24F2689D8D7Q34566088-B3A57FBF-9B16-4996-82FE-C6E703A6D68BQ34629955-8AB158D6-826A-4BDC-B6A6-B1D05F0BB3BCQ35975958-70B20709-6C9B-42DA-91AD-6F5A9A003515Q36115998-558489AA-CD6C-49F4-9D1C-0EF51C099F86Q36145455-FEA9C440-0A69-4BA8-8A38-13748133F14DQ36292760-CEF257E3-D927-4C62-B628-3253CCF4EAEEQ36468076-B5613DB4-7106-4A9B-BBAD-8326EA474B3DQ36620999-FB363055-4BD6-478B-A25E-2802C0F1CB6FQ36988384-5940D300-274B-4841-A474-C3183CBA8967Q37118467-A085F5B5-2157-4D65-A197-F1CB6F226A84Q37938298-3EAFDF50-BC88-4D5E-A926-25FB183A478AQ37938316-D45EB77C-026D-49A7-8744-6F6516634CFFQ40441448-B0A24A78-A86B-4106-9718-A78D5BAC3E9FQ53339815-A9AC0EE8-D8D9-43EC-A964-8FDF6DA54CDAQ58215312-746AC872-238D-40D1-8E71-FB23732630B9
P2860
Dose-response in the treatment of breast cancer: a critical review.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Dose-response in the treatment of breast cancer: a critical review.
@en
Dose-response in the treatment of breast cancer: a critical review.
@nl
type
label
Dose-response in the treatment of breast cancer: a critical review.
@en
Dose-response in the treatment of breast cancer: a critical review.
@nl
prefLabel
Dose-response in the treatment of breast cancer: a critical review.
@en
Dose-response in the treatment of breast cancer: a critical review.
@nl
P2093
P1476
Dose-response in the treatment of breast cancer: a critical review.
@en
P2093
I C Henderson
P304
P356
10.1200/JCO.1988.6.9.1501
P407
P577
1988-09-01T00:00:00Z